TR200102168T2 - BHV-1 geni silinmiş virüs aşısı. - Google Patents

BHV-1 geni silinmiş virüs aşısı.

Info

Publication number
TR200102168T2
TR200102168T2 TR2001/02168T TR200102168T TR200102168T2 TR 200102168 T2 TR200102168 T2 TR 200102168T2 TR 2001/02168 T TR2001/02168 T TR 2001/02168T TR 200102168 T TR200102168 T TR 200102168T TR 200102168 T2 TR200102168 T2 TR 200102168T2
Authority
TR
Turkey
Prior art keywords
animals
bhv
virus vaccine
infected
gal
Prior art date
Application number
TR2001/02168T
Other languages
English (en)
Inventor
I. Chowdhury Shafiqul
Original Assignee
Kansas State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kansas State University Research Foundation filed Critical Kansas State University Research Foundation
Publication of TR200102168T2 publication Critical patent/TR200102168T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Sigir herpesvirüs 1'in (BHV-1) glikoprotein E(gE) kodlayan tabii bölgesinin bir bölümünün silinmesini müteatip islevsel bir yabanci B-gal'yi ihtiva eden bir plasmitin gE lokusuna yerlestirilmesi ile emniyetli canli bir rekombinan virüs ve bir asili hayvanlarla enfekte olmus hayvanlarin birbbirlerinde ayrit edilebilmeleri için immünolojik bir isaret olarak kullanilmaktadir. Ayrica B-gal üretimi sayesinde asilanmis hayvanlarda gE3 1IBRB virüs replikasyonu kolaylikla degerlendirilmakta ve bir fenotip isaretleyici olarak, bu hayvanlarin enfekte hayvanlarda olusan yabani tipe virüs replikasyonundan ayirt edilmeleri saglanmaktadir.
TR2001/02168T 1999-01-29 2000-01-18 BHV-1 geni silinmiş virüs aşısı. TR200102168T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/240,173 US6284251B1 (en) 1996-02-26 1999-01-29 BHV-1 gene-deleted virus vaccine

Publications (1)

Publication Number Publication Date
TR200102168T2 true TR200102168T2 (tr) 2001-12-21

Family

ID=22905424

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02168T TR200102168T2 (tr) 1999-01-29 2000-01-18 BHV-1 geni silinmiş virüs aşısı.

Country Status (26)

Country Link
US (1) US6284251B1 (tr)
EP (1) EP1155119B1 (tr)
JP (2) JP2002535000A (tr)
CN (1) CN1197961C (tr)
AT (1) ATE342731T1 (tr)
AU (1) AU776261B2 (tr)
BG (1) BG105701A (tr)
BR (1) BR0007855A (tr)
CA (1) CA2359177C (tr)
CZ (1) CZ20012589A3 (tr)
DE (1) DE60031374T2 (tr)
DK (1) DK1155119T3 (tr)
EA (1) EA005736B1 (tr)
EE (1) EE200100396A (tr)
ES (1) ES2269101T3 (tr)
HK (1) HK1042512B (tr)
HR (1) HRP20010476B1 (tr)
HU (1) HUP0200560A2 (tr)
NO (1) NO20013697L (tr)
NZ (1) NZ512125A (tr)
PT (1) PT1155119E (tr)
SK (1) SK10702001A3 (tr)
TR (1) TR200102168T2 (tr)
UA (1) UA75035C2 (tr)
WO (1) WO2000044884A1 (tr)
YU (1) YU45601A (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2193842B1 (es) * 2001-06-28 2005-06-01 Consejo Superior De Investigaciones Cientificas Virus recombinante de la fiebre aftosa que carece del sitio antigenico a y su utilizacion como vacuna marcada.
CN101353670B (zh) * 2007-07-27 2012-07-04 中国农业科学院哈尔滨兽医研究所 牛传染性鼻气管炎病毒重组毒株、其构建方法及应用
US8877211B2 (en) 2011-06-27 2014-11-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Bovine herpes virus vaccine with multiple mutations
CN104640991B (zh) * 2012-07-04 2017-09-19 昆士兰州农渔林业部 重组低毒力1型牛疱疹病毒(BoHV‑1)疫苗载体
ES2847203T3 (es) * 2014-08-01 2021-08-02 The Board Of Supervisors Of Louisiana State Univ And Agricultural And Mechanical College Detección y tratamiento de herpesvirus bovino
CN107893056B (zh) * 2017-12-13 2019-08-27 江苏省农业科学院 山羊疱疹病毒ⅰ型疫苗株及其应用
CN108690835B (zh) * 2018-05-30 2021-08-31 内蒙古元山生物科技有限公司 一株I型牛疱疹病毒gE缺失毒株及其获取方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305323D0 (en) 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
WO1987000862A1 (en) 1985-07-29 1987-02-12 The Upjohn Company Virus vaccine
US4703011A (en) 1985-11-12 1987-10-27 Novagene, Inc. Thymidine kinase deletion mutants of bovine herpesvirus-1
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
AU3579089A (en) 1988-05-03 1989-11-29 Upjohn Company, The Glycoprotein h of herpes viruses
FR2693472B1 (fr) 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
NL9100989A (nl) * 1991-06-07 1993-01-04 Stichting Centr Diergeneeskund Bovine herpesvirus type 1 deletiemutanten, daarop gebaseerde vaccins, diagnostische kits voor detectie van bovine herpesvirus type 1.
US5874279A (en) * 1991-07-18 1999-02-23 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
WO1993002104A1 (en) 1991-07-18 1993-02-04 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
CA2057387A1 (en) 1991-12-11 1993-06-12 Lorne A. Babiuk Recombinant bovine herpesvirus type 1 polypeptides and vaccines
ES2074965B1 (es) * 1994-01-31 1996-05-01 Hipra Lab Sa Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Also Published As

Publication number Publication date
CN1364193A (zh) 2002-08-14
BG105701A (bg) 2002-03-29
NO20013697D0 (no) 2001-07-27
DK1155119T3 (da) 2007-02-05
WO2000044884A1 (en) 2000-08-03
HK1042512B (zh) 2007-05-11
UA75035C2 (en) 2006-03-15
US6284251B1 (en) 2001-09-04
SK10702001A3 (sk) 2002-01-07
ATE342731T1 (de) 2006-11-15
PT1155119E (pt) 2006-12-29
JP2002535000A (ja) 2002-10-22
NO20013697L (no) 2001-08-27
AU776261B2 (en) 2004-09-02
BR0007855A (pt) 2001-10-23
JP2007020574A (ja) 2007-02-01
NZ512125A (en) 2003-01-31
EP1155119A1 (en) 2001-11-21
ES2269101T3 (es) 2007-04-01
EE200100396A (et) 2002-10-15
DE60031374D1 (de) 2006-11-30
EP1155119A4 (en) 2003-01-02
EA005736B1 (ru) 2005-06-30
HK1042512A1 (en) 2002-08-16
CN1197961C (zh) 2005-04-20
AU2615200A (en) 2000-08-18
CZ20012589A3 (cs) 2002-03-13
DE60031374T2 (de) 2007-08-30
CA2359177C (en) 2007-07-03
HRP20010476A2 (en) 2002-08-31
HRP20010476B1 (en) 2007-09-30
YU45601A (sh) 2005-06-10
CA2359177A1 (en) 2000-08-03
EP1155119B1 (en) 2006-10-18
EA200100720A1 (ru) 2002-02-28
HUP0200560A2 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
Yu et al. DNA-mediated protection against classical swine fever virus
ES2061500T3 (es) Diagnosis y vacunas de la hepatitis delta su preparacion y uso.
CA2334857A1 (en) Interferon inducing genetically engineered attenuated viruses
Hu et al. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein
ES2070997T3 (es) Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
DE69535359D1 (de) Rekombinantes herpesvirus aus trufhähnen und seine verwendungen
EP0261940A3 (en) Pseudorabies vaccines and dna vectors for recombination with pox viruses
IL77694A (en) Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging
TR200102168T2 (tr) BHV-1 geni silinmiş virüs aşısı.
CY1106570T1 (el) Σταθερες, εξασθενημενες μεταλλαγμενες μορφες ιου λυσσας και ζωντανια εμβολια αυτων
EA200300215A1 (ru) Вакцинация против вирусов герпеса, ассоциированных с хозяйской клеткой
ES8201020A1 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
DE69332264D1 (de) Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe
Sobrino et al. Synthetic peptide vaccines: foot-and-mouth disease virus as a model
YU49995A (sh) Polinukleotidna vakcina za virus herpesa
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Cavanagh Viral and bacterial vectors of immunogenes
HUP0002374A2 (hu) Egy diszfunkcionális 71 gén régiót tartalmazó rekombináns 1-es típusú ló herpeszvírus (EHV-1) és alkalmazása vakcinaként
ES2012815A6 (es) Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.
Tikhonenko Prospects and achievements in the development of genetically engineered antiviral vaccines.
CA2304991A1 (en) Synthetic gene of bovine viral diarrhoea virus
CY1114437T1 (el) Εμβολια με βαση πολυνουκλεοτιδιο βελτιστοποιημενου κωδικονιου εναντι μολυνσης ανθρωπινου κυτομεγαλοϊου